Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus-Reference-Cited by-同舟云学术

Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus

Published:2009-07 Issue:3 Volume:385 Page:390-394
ISSN:0006-291X
Container-title:Biochemical and Biophysical Research Communications
language:en
Short-container-title:Biochemical and Biophysical Research Communications

Author:

Rungrotmongkol Thanyada,Intharathep Pathumwadee,Malaisree Maturos,Nunthaboot Nadtanet,Kaiyawet Nopphorn,Sompornpisut Pornthep,Payungporn Sanchai,Poovorawan Yong,Hannongbua Supot

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry,Biophysics

Reference23 articles.

1. WHO, Epidemic and Pandemic Alert and Response (EPR). Available from: , (accessed May 2009).

2. Emedicine. Available from:

3. WHO, Media centre. Influenza A(H1N1). Available from: , (accessed May 2009).

4. Antiviral agents active against influenza A virus;De Clercq;Nat. Rev. Drug Discov.,2006

5. CDC, Antiviral Drugs and H1N1 Flu (Swine Flu). Available from: , (accessed May 2009).

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Source of oseltamivir resistance due to single E276D, R292K, and double E276D/R292K mutations in H10N4 influenza neuraminidase;Journal of Molecular Liquids;2021-03

2. Influenza Virus: Small Molecule Therapeutics and Mechanisms of Antiviral Resistance;Current Medicinal Chemistry;2019-01-07

3. Molecular Docking Simulation of Neuraminidase Influenza A Subtype H1N1 with Potential Inhibitor of Disulfide Cyclic Peptide (DNY, NNY, LRL);IOP Conference Series: Materials Science and Engineering;2018-04

4. Verdinexor Targeting of CRM1 is a Promising Therapeutic Approach against RSV and Influenza Viruses;Viruses;2018-01-21

5. The emerging influenza virus threat: status and new prospects for its therapy and control;Archives of Virology;2018-01-10